Hu L., Zhao C., Chen Z., Hu G., Li X., Li Q. An emerging strategy for targeted therapy of pulmonary arterial hypertension: Vasodilation plus vascular remodeling inhibition. Drug Discov Today, 2022, 27(5): 1457-1463.
Hits:
|
Pre One:Hu L., Wang G., Zhao C., Peng Z., Tao L., Chen Z., Hu G., Li Q. Identification of selective homeodomain interacting protein kinase 2 inhibitors, a potential treatment for renal fibrosis. Bioorg Chem, 2022, 126: 105866.
Next One:Hao C., Cao M., Ouyang H., Chen Z., Hu G., Li Q. Recent advances in the development of HIPK2 inhibitors as anti-renal fibrosis agents. Future Med. Chem., 2023, 15(5): 453-465.
